Evista 60mg

Forms and dosages

Evista is supplied as 60mg oral tablets. The standard dose is 60mg once daily, taken with or without food at any time of day. There is no need to adjust the dose for renal or hepatic impairment unless severe. Calcium and vitamin D supplementation is typically recommended alongside Evista for women at risk of inadequate intake, since the drug works through preserving bone mineral density that requires substrate.

Indications

Evista is approved for prevention and treatment of postmenopausal osteoporosis and for reduction of invasive breast cancer risk in postmenopausal women at increased risk. According to current osteoporosis guidelines, raloxifene is a reasonable option for postmenopausal women with osteoporosis who also have elevated breast cancer risk, though bisphosphonates remain first-line for most patients due to greater non-vertebral fracture reduction.